Although one study conducted in GH-treated children showed a safety profile of GH, the incidence of type 2 diabetes was increased in relation to the general population, especially in patients with a risk factors of diabetes such as patients with TS (45). This evidence concerns the gene GH1 and diabetes mellitus.